Evidence map›Paper›PMID 29207475›Full record

ReviewInternational journal of molecular sciences2017

Function of microRNAs in the Osteogenic Differentiation and Therapeutic Application of Adipose-Derived Stem Cells (ASCs).

Walter M Hodges, Frederick O'Brien, Sadanand Fulzele, Mark W Hamrick

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Association betweenCell cycle (Georgetown, Tex.) · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Cell Cycle Regulation of Stem Cells by MicroRNAs.Stem cell reviews and reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Walter M HodgesDepartment of Cellular Biology & Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. whodges@augusta.edu.ORCID 0000-0002-6687-4806
Frederick O'BrienDwight D. Eisenhower Army Medical Center, Fort Gordon, Augusta, GA 30912, USA. fpobrien3@gmail.com.
Sadanand FulzeleDepartment of Cellular Biology & Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. sfulzele@augusta.edu.
Mark W HamrickDepartment of Cellular Biology & Anatomy, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. mhamrick@augusta.edu.
Augusta University · USEisenhower Medical Center · US

Funding

THE LEPTIN-IGF1 AXIS IN MUSCULOSKELETAL AGINGP01AG036675 · NIA · AUGUSTA UNIVERSITY · PI Meghan E. McGee-Lawrence · 2011 to 2026
$31.5M
NIA NIH HHS P01 AG036675
6 · The paper itself

Abstract

Traumatic wounds with segmental bone defects represent substantial reconstructive challenges. Autologous bone grafting is considered the gold standard for surgical treatment in many cases, but donor site morbidity and associated post-operative complications remain a concern. Advances in regenerative techniques utilizing mesenchymal stem cell populations from bone and adipose tissue have opened the door to improving bone repair in the limbs, spine, and craniofacial skeleton. The widespread availability, ease of extraction, and lack of immunogenicity have made adipose-derived stem cells (ASCs) particularly attractive as a stem cell source for regenerative strategies. Recently it has been shown that small, non-coding miRNAs are involved in the osteogenic differentiation of ASCs. Specifically, microRNAs such as miR-17, miR-23a, and miR-31 are expressed during the osteogenic differentiation of ASCs, and appear to play a role in inhibiting various steps in bone morphogenetic protein-2 (BMP2) mediated osteogenesis. Importantly, a number of microRNAs including miR-17 and miR-31 that act to attenuate the osteogenic differentiation of ASCs are themselves stimulated by transforming growth factor β-1 (TGFβ-1). In addition, transforming growth factor β-1 is also known to suppress the expression of microRNAs involved in myogenic differentiation. These data suggest that preconditioning strategies to reduce TGFβ-1 activity in ASCs may improve the therapeutic potential of ASCs for musculoskeletal application. Moreover, these findings support the isolation of ASCs from subcutaneous fat depots that tend to have low endogenous levels of TGFβ-1 expression.

Indexed as

Bone RegenerationOsteogenesisAdipocytesBone Morphogenetic Protein 2Cell DifferentiationHumansMicroRNAsStem CellsStem Cell TransplantationSubcutaneous FatTransforming Growth Factor betaBMP2 protein, humanBone Morphogenetic Protein 2MicroRNAsMIRN17 microRNA, humanMIRN23a microRNA, humanMIRN31 microRNA, humanTransforming Growth Factor betaBMP2bone repairmiR-17miR-23amiR-31TGFβ1

Identifiers

PMID29207475
PMCPMC5751200
OpenAlexW2774608958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.